Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
99 Results for "
DFNB
" in MedChemExpress (MCE) Product Catalog:
Products (99)
99 Results for "DFNB" in MCE Product Catalog:
Cat. No.: HY-P70970
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SERPINB6; Serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 6; Prev. PI6; PI-6; Prev. DFNB91; Protease Inhibitor 6 (Placental Thrombin Inhibitor); PTI; Deafness, Autosomal Recessive 91; CAP; Peptidase Inhibitor 6; Cytoplasmic Antiproteinase; MSTP057
Species:
Human
Source:
E. coli
Cat. No.: HY-P76640
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SERPINB6; Serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 6; Prev. PI6; PI-6; Prev. DFNB91; Protease Inhibitor 6 (Placental Thrombin Inhibitor); PTI; Deafness, Autosomal Recessive 91; CAP; Peptidase Inhibitor 6; Cytoplasmic Antiproteinase; MSTP057
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P703412
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: SLC26A5; Solute Carrier Family 26 (Anion Exchanger), Member 5; Prev. PRES; Prestin; PRESTIN; Deafness, Neurosensory, Autosomal Recessive, 61; DFNB61; SLC26A5 Protein; Solute Carrier Family 26 Member 5; Prestin (Motor Protein)
Species:
Human
Source:
HEK293
Cat. No.: HY-P70714
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P72934
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Canine
Source:
HEK293
Cat. No.: HY-P72941
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P72942
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Rat
Source:
HEK293
Cat. No.: HY-P75675
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CIB2; DNA-Dependent Protein Kinase Catalytic Subunit-Interacting Protein 2; Prev. DFNB48; Deafness, Autosomal Recessive 48; Prev. USH1J; Kinase Interacting Protein 2; KIP2; Kinase-Interacting Protein 2; Calcium And Integrin-Binding Family Member 2; KIP 2
Species:
Human
Source:
E. coli
Cat. No.: HY-P75675A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CIB2; DNA-Dependent Protein Kinase Catalytic Subunit-Interacting Protein 2; Prev. DFNB48; Deafness, Autosomal Recessive 48; Prev. USH1J; Kinase Interacting Protein 2; KIP2; Kinase-Interacting Protein 2; Calcium And Integrin-Binding Family Member 2; KIP 2
Species:
Human
Source:
E. coli
Cat. No.: HY-P70715
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P72940
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P702440
Purity: Purity analysis by SDS-PAGE is not available for VLP proteins.
Synonyms: SLC26A4; Solute Carrier Family 26, Member 4; Prev. DFNB4; Uncharacterized Protein SLC26A4; PDS; Pendred Syndrome; Pendrin; TDH2B; Solute Carrier Family 26 (Anion Exchanger), Member 4; EVA; Sodium-Independent Chloride/Iodide Transporter; Solute Carrier Fam
Species:
Human
Source:
HEK293
Cat. No.: HY-P703413
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SLC26A5; Solute Carrier Family 26 (Anion Exchanger), Member 5; Prev. PRES; Prestin; PRESTIN; Deafness, Neurosensory, Autosomal Recessive, 61; DFNB61; SLC26A5 Protein; Solute Carrier Family 26 Member 5; Prestin (Motor Protein)
Species:
Human
Source:
HEK293
Cat. No.: HY-P704663
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Canine
Source:
HEK293
Cat. No.: HY-P72376
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P72624
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P72935
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Rhesus Macaque
Cynomolgus
Source:
HEK293
Cat. No.: HY-P72938
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P78490
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P72936
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Rhesus Macaque
Cynomolgus
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
